Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Olodaterol is a selective agonist of β2-adrenergic receptors (β2-ARs; EC50s = 97.7 and 2,725 nM for human β2- and β1-ARs, respectively).1 In vivo, olodaterol completely reverses acetylcholine-induced bronchoconstriction without cardiovascular side effects in guinea pigs. It also exhibits dose-dependent bronchoprotection in a beagle model of acetylcholine-induced bronchoconstriction for a period of 24 hours, indicating potential for once-daily dosing.2 Formulations containing olodaterol have been used to treat bronchoconstriction associated with chronic obstructive pulmonary disease.3
WARNING This product is not for human or veterinary use.
1. Discovery of olodaterol, a novel inhaled β2-
2. Pharmacological characterization of olodaterol, a novel inhaled β2-
3. Systematic review comparing LABA, olodaterol, and indacaterol: Limitations. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 1331-1333 (2014).